市場調查報告書

全球細胞療法設備市場:產業分析,規模,佔有率,成長,趨勢,及預測(2018年∼2025年)

Global Cell Therapy Instrument Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2018 to 2025

出版商 Value Market Research 商品編碼 916366
出版日期 內容資訊 英文 106 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球細胞療法設備市場:產業分析,規模,佔有率,成長,趨勢,及預測(2018年∼2025年) Global Cell Therapy Instrument Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2018 to 2025
出版日期: 2019年11月01日內容資訊: 英文 106 Pages
簡介

本報告提供全球細胞療法設備市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,產品·用途·細胞類型·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 報告的說明
  • 調查範圍
  • 調查方法

第2章 摘要整理

  • 市場概要
  • 全球市場的概述

第3章 產業分析

  • 簡介
  • 市場成長要素
  • 市場阻礙因素
  • 市場機會
  • 趨勢
  • 波特的五力分析
  • 市場魅力分析

第4章 價值鏈分析

  • 價值鏈分析
  • 材料分析
  • 潛在買主清單
  • 行銷流通管道

第5章 市場分析:各產品

  • 概要
  • 市場分析
  • 消耗品
  • 設備
  • 軟體

第6章 市場分析:各用途

  • 概要
  • 市場分析
  • 細胞處理
  • 細胞的保存,分配及處理
  • 流程監視·品管

第7章 市場分析:各細胞類型

  • 概要
  • 市場分析
  • 人細胞
  • 動物細胞

第8章 市場分析:各終端用戶

  • 概要
  • 市場分析
  • 生命科學企業
  • 研究機關

第9章 市場分析:各地區

  • 地區預測
  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第10章 競爭情形

  • 市場競爭
  • 聯盟/合作/契約
  • 合併·收購
  • 新產品的銷售
  • 其他開發

第11章 企業簡介

  • 企業佔有率分析
  • 市場集中率
  • BD BIOSCIENCE
  • DANAHER (BECKMAN COULTER, INC).
  • GENERAL ELECTRIC
  • LONZA
  • MERCK KGAA
  • MILTENYI BIOTEC
  • SARTORIUS AG
  • STEMCELL TECHNOLOGIES INC.
  • Terumo Corporation
  • THERMO FISHER SCIENTIFIC INC.
目錄

The report on global Cell Therapy Instrument market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2018-2025. The market size in terms of revenue (USD MN) is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints).

  • Drivers
  • Increase in count of cancer cell-based therapy clinical trials
  • Promotion cell-based research from government and private organizations
  • Restraints
  • High cost of cell-based research

Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:

  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Till: 2025

The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.

The report classifies the market into different segments based on product, application, cell type and end-user. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.

The report also covers the complete competitive landscape of the worldwide market with company profiles of key players. A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.

SEGMENTATIONS IN THE REPORT:

By Product:

  • Consumables
  • Equipment
  • Software

By Application:

  • Cell Processing
  • Cell Preservation Distribution & Handling
  • Process Monitoring & Quality Control

By Cell Type:

  • Human Cells
  • Animal Cells

By End-User:

  • Life Science Companies
  • Research Institutes

By Geography:

  • North America (NA) - US & Rest of North America
  • Europe (EU) - UK, Germany, France & Rest of Europe
  • Asia Pacific (APAC) - China, Japan, India & Rest of APAC
  • Latin America (LA) - Brazil & Rest of Latin America
  • Middle East & Africa (MEA) - Middle East and Africa

Table of Contents

1 PREFACE

  • 1.1. REPORT DESCRIPTION
    • 1.1.1. OBJECTIVE
    • 1.1.2. TARGET AUDIENCE
    • 1.1.3. UNIQUE SELLING PROPOSITION (USP) & OFFERINGS
  • 1.2. RESEARCH SCOPE
  • 1.3. RESEARCH METHODOLOGY
    • 1.3.1. MARKET RESEARCH PROCESS
    • 1.3.2. MARKET RESEARCH METHODOLOGY
      • 1.3.2.1. SECONDARY RESEARCH
      • 1.3.2.2. PRIMARY RESEARCH
      • 1.3.2.3. MODELS

2 EXECUTIVE SUMMARY

  • 2.1. MARKET HIGHLIGHTS
  • 2.2. GLOBAL CELL THERAPY INSTRUMENT MARKET: SNAPSHOT

3 CELL THERAPY INSTRUMENT - INDUSTRY ANALYSIS

  • 3.1. INTRODUCTION
  • 3.2. MARKET DRIVERS
    • 3.2.1. DRIVER 1
    • 3.2.2. DRIVER 2
  • 3.3. MARKET RESTRAINTS
    • 3.3.1. RESTRAINT 1
    • 3.3.2. RESTRAINT 2
  • 3.4. OPPORTUNITIES
    • 3.4.1. OPPORTUNITY 1
  • 3.5. TRENDS
    • 3.5.1. TREND 1
    • 3.5.2. TREND 2
  • 3.6. PORTER'S FIVE FORCE ANALYSIS
  • 3.7. CELL THERAPY INSTRUMENT: MARKET ATTRACTIVENESS ANALYSIS
    • 3.7.1. MARKET ATTRACTIVE ANALYSIS BY PRODUCT
    • 3.7.2. MARKET ATTRACTIVE ANALYSIS BY APPLICATION
    • 3.7.3. MARKET ATTRACTIVE ANALYSIS BY CELL TYPE
    • 3.7.4. MARKET ATTRACTIVE ANALYSIS BY REGION

4 VALUE CHAIN ANALYSIS

  • 4.1. CELL THERAPY INSTRUMENT: VALUE CHAIN ANALYSIS
  • 4.2. CELL THERAPY INSTRUMENT RAW MATERIAL ANALYSIS
    • 4.2.1. LIST OF RAW MATERIALS
    • 4.2.2. CELL THERAPY INSTRUMENT RAW MATERIAL MANUFACTURES LIST
    • 4.2.3. PRICE TREND OF CELL THERAPY INSTRUMENT KEY RAW MATERIALS
  • 4.3. LIST OF POTENTIAL BUYERS
  • 4.4. MARKETING CHANNEL
    • 4.4.1. DIRECT MARKETING
    • 4.4.2. INDIRECT MARKETING
    • 4.4.3. MARKETING CHANNEL DEVELOPMENT TREND

5 GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY PRODUCT

  • 5.1. OVERVIEW BY PRODUCT
  • 5.2. GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY PRODUCT
  • 5.3. CONSUMABLES
    • 5.3.1. OVERVIEW
  • 5.4. EQUIPMENT
    • 5.4.1. OVERVIEW
  • 5.5. SOFTWARE
    • 5.5.1. OVERVIEW

6 GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY APPLICATION

  • 6.1. OVERVIEW BY APPLICATION
  • 6.2. GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY APPLICATION
  • 6.3. CELL PROCESSING
    • 6.3.1. OVERVIEW
  • 6.4. CELL PRESERVATION DISTRIBUTION & HANDLING
    • 6.4.1. OVERVIEW
  • 6.5. PROCESS MONITORING & QUALITY CONTROL
    • 6.5.1. OVERVIEW

7 GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY CELL TYPE

  • 7.1. OVERVIEW BY CELL TYPE
  • 7.2. GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY CELL TYPE
  • 7.3. HUMAN CELLS
    • 7.3.1. OVERVIEW
  • 7.4. ANIMAL CELLS
    • 7.4.1. OVERVIEW

8 GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY END-USER

  • 8.1. OVERVIEW BY END-USER
  • 8.2. GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY END-USER
  • 8.3. LIFE SCIENCE COMPANIES
    • 8.3.1. OVERVIEW
  • 8.4. RESEARCH INSTITUTES
    • 8.4.1. OVERVIEW

9 GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. REGIONAL OUTLOOK
  • 9.2. INTRODUCTION
  • 9.3. NORTH AMERICA
    • 9.3.1. OVERVIEW
    • 9.3.2. NORTH AMERICA CELL THERAPY INSTRUMENT MARKET ESTIMATE BY MARKET SEGMENT
    • 9.3.3. NORTH AMERICA CELL THERAPY INSTRUMENT MARKET ESTIMATE BY COUNTRY
    • 9.3.4. UNITED STATE
    • 9.3.5. REST OF NORTH AMERICA
  • 9.4. EUROPE
    • 9.4.1. OVERVIEW
    • 9.4.2. EUROPE CELL THERAPY INSTRUMENT MARKET ESTIMATE BY MARKET SEGMENT
    • 9.4.3. EUROPE CELL THERAPY INSTRUMENT MARKET ESTIMATE BY COUNTRY
    • 9.4.4. UNITED KINGDOM
    • 9.4.5. FRANCE
    • 9.4.6. GERMANY
    • 9.4.7. REST OF EUROPE
  • 9.5. ASIA PACIFIC
    • 9.5.1. OVERVIEW
    • 9.5.2. ASIA PACIFIC CELL THERAPY INSTRUMENT MARKET ESTIMATE BY MARKET SEGMENT
    • 9.5.3. ASIA PACIFIC CELL THERAPY INSTRUMENT MARKET ESTIMATE BY COUNTRY
    • 9.5.4. CHINA
    • 9.5.5. JAPAN
    • 9.5.6. INDIA
    • 9.5.7. REST OF ASIA PACIFIC
  • 9.6. LATIN AMERICA
    • 9.6.1. OVERVIEW
    • 9.6.2. LATIN AMERICA CELL THERAPY INSTRUMENT MARKET ESTIMATE BY MARKET SEGMENT
    • 9.6.3. LATIN AMERICA CELL THERAPY INSTRUMENT MARKET ESTIMATE BY COUNTRY
    • 9.6.4. BRAZIL
    • 9.6.5. REST OF LATIN AMERICA
  • 9.7. MIDDLE EAST & AFRICA
    • 9.7.1. OVERVIEW
    • 9.7.2. MIDDLE EAST & AFRICA CELL THERAPY INSTRUMENT MARKET ESTIMATE BY MARKET SEGMENT
    • 9.7.3. MIDDLE EAST & AFRICA CELL THERAPY INSTRUMENT MARKET ESTIMATE BY COUNTRY
    • 9.7.4. MIDDLE EAST
    • 9.7.5. AFRICA

10 COMPETITIVE LANDSCAPE OF THE CELL THERAPY INSTRUMENT COMPANIES

  • 10.1. CELL THERAPY INSTRUMENT MARKET COMPETITION
  • 10.2. PARTNERSHIP/COLLABORATION/AGREEMENT
  • 10.3. MERGER AND ACQUISITIONS
  • 10.4. NEW PRODUCT LAUNCH
  • 10.5. OTHER DEVELOPMENTS

11 COMPANY PROFILES OF CELL THERAPY INSTRUMENT INDUSTRY

  • 11.1. COMPANY SHARE ANALYSIS
  • 11.2. MARKET CONCENTRATION RATE
  • 11.3. BD BIOSCIENCE
    • 11.3.1. COMPANY OVERVIEW:
    • 11.3.2. FINANCIALS:
    • 11.3.3. PRODUCTS:
    • 11.3.4. RECENT DEVELOPMENTS:
  • 11.1. DANAHER (BECKMAN COULTER, INC).
    • 11.1.1. COMPANY OVERVIEW:
    • 11.1.2. FINANCIALS:
    • 11.1.3. PRODUCTS:
    • 11.1.4. RECENT DEVELOPMENTS:
  • 11.1. GENERAL ELECTRIC
    • 11.1.1. COMPANY OVERVIEW:
    • 11.1.2. FINANCIALS:
    • 11.1.3. PRODUCTS:
    • 11.1.4. RECENT DEVELOPMENTS:
  • 11.2. LONZA
    • 11.2.1. COMPANY OVERVIEW:
    • 11.2.2. FINANCIALS:
    • 11.2.3. PRODUCTS:
    • 11.2.4. RECENT DEVELOPMENTS:
  • 11.3. MERCK KGAA
    • 11.3.1. COMPANY OVERVIEW:
    • 11.3.2. FINANCIALS:
    • 11.3.3. PRODUCTS:
    • 11.3.4. RECENT DEVELOPMENTS:
  • 11.1. MILTENYI BIOTEC
    • 11.1.1. COMPANY OVERVIEW:
    • 11.1.2. FINANCIALS:
    • 11.1.3. PRODUCTS:
    • 11.1.4. RECENT DEVELOPMENTS:
  • 11.2. SARTORIUS AG
    • 11.2.1. COMPANY OVERVIEW:
    • 11.2.2. FINANCIALS:
    • 11.2.3. PRODUCTS:
    • 11.2.4. RECENT DEVELOPMENTS:
  • 11.3. STEMCELL TECHNOLOGIES INC.
    • 11.3.1. COMPANY OVERVIEW:
    • 11.3.2. FINANCIALS:
    • 11.3.3. PRODUCTS:
    • 11.3.4. RECENT DEVELOPMENTS:
  • 11.4. TERUMO CORPORATION
    • 11.4.1. COMPANY OVERVIEW:
    • 11.4.2. FINANCIALS:
    • 11.4.3. PRODUCTS:
    • 11.4.4. RECENT DEVELOPMENTS:
  • 11.5. THERMO FISHER SCIENTIFIC INC.
    • 11.5.1. COMPANY OVERVIEW:
    • 11.5.2. FINANCIALS:
    • 11.5.3. PRODUCTS:
    • 11.5.4. RECENT DEVELOPMENTS:
Back to Top